The results of this study suggest that resveratrol, at the dose range of pharmacologic-achievable concentrations, upregulated PD-L1 expression in lung cancer cells, and that is essential for suppression of the T-cell-mediated immune response. This evidence concerns the gene CD274 and lung carcinoma.